Dr. maryam koosha|quality of life|Best Researcher Award

Published on by Top Pharmaceutical

Dr. maryam koosha|quality of life|Best Researcher Award

Dr. maryam koosha at Institute for humanities and cultural studies,Iran

PROFILE  

Google scholar

 

 

🎓 Early Academic Pursuits

Maryam Koosha was born on December 9, 1979, in Najafabad, Isfahan Province, Iran. Driven by a passion for understanding societal dynamics, she pursued a Bachelor’s Degree in Public Health at Kerman University of Medical Sciences. Her academic journey continued with a Master’s in Sociology from Tehran Central Branch, Islamic Azad University, where she graduated with distinction (GPA 18.22/20). Her Master’s thesis, “The Impact of Socioeconomic Status on Coping Behavior of Breast Cancer Patients”, set the stage for her lifelong commitment to social health research. This formative work was conducted in collaboration with the Breast Cancer Research Center at Jihad University, illustrating her early dedication to addressing the intersection of social factors and health.

Koosha earned her Ph.D. in Social Welfare at Allameh Tabatabai University, Tehran, where her dissertation, “Analysis of Social Health Policies for the Elderly from the 1980s to the Present and Policy Requirements”, examined the evolution of social policies affecting elderly populations. This analysis underscored her commitment to social welfare, particularly within aging demographics, and her insights highlighted the policy gaps and future needs in elderly social health.

👩‍💼 Professional Endeavors

Throughout her career, Koosha has worked as a social research specialist across various institutes and research groups. She held prominent roles at the Institute for Humanities and Social Studies, Medical Informatics Group, Women’s Disease Prevention Group, and the Quality of Life Research Group. In each role, she brought her expertise in both qualitative and quantitative research, contributing valuable insights on health literacy, socioeconomic impacts on health, and social support structures.

Her tenure with these organizations spans over six years, during which she led numerous high-impact studies focusing on preventive behavior, lifestyle factors, and coping strategies among vulnerable populations, particularly breast cancer patients. Koosha’s work has not only provided data-driven recommendations for improving health policies but has also directly influenced awareness and preventive measures in women’s health.

🔬 Contributions and Research Focus

Koosha’s research contributions have centered around social determinants of health, preventive behavior, and the role of socioeconomic factors in coping mechanisms among breast cancer patients. Her key projects include:

  • Analysis of Socioeconomic Status and Coping Behaviors: A cross-sectional study comparing breast cancer patients’ lifestyles with non-patients, leading to targeted recommendations on social support structures.
  • Preventive Behavior Studies: Investigating the impact of social support and satisfaction on preventive behavior, which significantly contributed to awareness-raising initiatives for early detection of breast cancer.
  • Health Literacy Assessment: A co-led project assessing health literacy among Iranian women with breast cancer, emphasizing the need for improved educational resources tailored to different literacy levels.

Additionally, Koosha has been a strong advocate for ethical practices in healthcare, co-investigating the study “Ethical Aspects and Professional Guidelines in Remote Health and Clinical Education”, a timely project given the rise of telemedicine and remote health education. Her research has emphasized that patient support systems and health literacy play a critical role in coping and preventive health behaviors, establishing her as a significant voice in medical sociology.

🏆 Accolades and Recognition

Koosha’s research has garnered widespread recognition. Notable awards include:

  • Best Researcher at Mo’tamed Cancer Research Institute (2018): A prestigious acknowledgment of her impactful work on breast cancer prevention and social health policies.
  • Best Speaker at the 12th International Breast Cancer Congress (2017): Her presentation on “Screening of Women and Influencing Factors in Iran” underscored her research’s practical implications, earning her acclaim from the medical community.
  • 1st Place National Award in 1996: Early in her career, she achieved a top position in a research competition on the “Economic-Social Activities of Women in Society and Influencing Factors”, demonstrating her long-standing commitment to gender and socioeconomic issues.

These accolades reflect not only her academic and research proficiency but also her ability to communicate complex findings to broader audiences effectively.

🌍 Impact and Influence

Koosha’s work has had a tangible impact on both academic and policy landscapes. Her studies have led to heightened awareness and enhanced policies around breast cancer prevention and elderly health. In particular, her insights into socioeconomic factors affecting health have guided policies that prioritize preventive care and health education. Her systematic review on “Breast Cancer Prevention (2005-2020)” has provided a foundation for medical professionals and policymakers to address barriers to screening and early detection, especially for underserved populations.

Her influence also extends to the educational domain; as an active member of the Iranian Sociological Association and the Iranian Association of Medical Sciences, Koosha has been involved in developing medical sociology curricula that emphasize preventive healthcare and social support.

🌟 Legacy and Future Contributions

Koosha’s research legacy is marked by her commitment to improving the social determinants of health. Moving forward, her focus remains on expanding elderly social health policies and refining cancer prevention strategies. She is actively working on publishing her findings in international journals, with recent publications in Archives of Gerontology and Geriatrics Plus and International Journal of Psychiatry, where her studies on elderly social health policies are poised to contribute to global policy development.

Her future goals include collaborating with international health organizations to further her research on preventive behavior and health literacy. As she continues to build on her impressive portfolio of research, Koosha remains a pioneering figure in social health, her work poised to influence both national and global health policies for years to come.

🎓Publication 

Status of breast cancer screening strategies and indicators in Iran: A scoping review

  • Authors   : Zahra Omidi, Maryam Koosha, Najme Nazeri, Nasim Khosravi, Sheida Zolfaghari, Shahpar Haghighat
  • Journal    : Research in Medical Sciences
  • Year         :2022

Supportive care of breast cancer patients in Iran: A systematic review

  • Authors   : Nasim Khosravi, Najmeh Nazeri, Vahid Farajivafa, Asiie Olfatbakhsh, Alireza Atashi, Maryam Koosha, Shahpar Haghighat
  • Journal    : Cancer Management
  • Year         :2019

Effectiveness of home-based exercise in breast cancer survivors: a randomized clinical trial

  • Authors   :Vahid Farajivafa, Nasim Khosravi, Nilofar Rezaee, Maryam Koosha, Shahpar Haghighat
  • Journal    :Medicine and Rehabilitation
  • Year         :2023

Evaluation of Socio-economic Status and its Impact on coping Behavior of Patients with Breast Cancer

  • Authors   : Maryam Koosha, Shahpar Haghighat, Roza Karampoor, Alieh Shekarbeygi, Alireza Bahrami, Hoda Tafazzoli-Harandi, Amir Lalegani
  • Journal    : Breast Disease
  • Year         :2017

A study of lifestyle factors associated with breast cancer patients in Iran

  • Authors   : Maryam Koosha, Azam Raoofi, Shahpar Haghighat, Effat Hatefnia
  • Journal    :health development
  • Year         :2019

Mr. Anil Kumar Gupta|Formulation Science|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Anil Kumar Gupta|Formulation Science|Best Researcher Award

Mr. Anil Kumar Gupta at Nepal Administrative Staff Cllege,Nepal

PROFILE  

ORCID

Scopus

 

🌱 Early Academic Pursuits

Anil Kumar Gupta embarked on his academic journey with a passion for population studies and education, beginning with a Bachelor’s degree in Population Education from Tribhuvan University. His dedication to excellence was evident early on, as he consistently achieved top ranks, earning First Division distinctions in both his B.Ed. and M.A. in Population Studies. He furthered his expertise with an MPhil in Development Studies from Kathmandu University, where he was recognized for academic distinction. Currently, he is pursuing a PhD in Development Studies at Kathmandu University, adding a robust research foundation to his extensive academic repertoire.

📈 Professional Endeavors

Anil Kumar Gupta holds the position of Deputy Director of Studies at the Nepal Administrative Staff College (NASC), where he contributes significantly to training and public administration. His role involves overseeing the development of programs tailored to enhance the administrative and governance capacities of Nepalese civil servants. In addition to his responsibilities at NASC, he has consulted on six high-impact projects, utilizing his expertise to influence public administration and governance. He is a recognized voice in South Asian public administration and an active General Member of the South Asian Network for Public Administration.

His career is also marked by his contributions to impactful studies and policy-oriented research, especially his role as a research manager in projects such as the Nepal National Governance Survey 2017/18 and the Capacity Needs Assessment for Federalism in 2019. These studies have guided policy formulation in Nepal, supporting federalization and inclusivity.

📚 Contributions and Research Focus

Anil’s research focuses on governance, development, and the political economy. With five journal articles published in indexed journals, he has contributed valuable insights to academia and policy discourse. His work includes pioneering gender inclusion research, where he led a comprehensive study on female leadership in local governance for the National Women Commission, Nepal. His approach combines evidence-based research with a practical focus on social equity, gender equality, and effective governance.

His training programs have also emphasized these themes, with courses on gender equality, social inclusion, and budgetary responsiveness, reinforcing his commitment to creating an inclusive governance model in Nepal.

🏆 Accolades and Recognition

Anil’s academic excellence and professional contributions have earned him several prestigious awards. In 2015, he was awarded the Nepal Bidhya Bhusan “Kha” (Gold Medal) for his outstanding academic achievements in Population Studies. His research prowess was further acknowledged internationally when he won Akira Nakamura’s Best Paper Award at the 2022 annual conference of the Asian Association for Public Administration. NASC recognized his dedication with the Best Employee Award in 2019, underscoring his valuable contributions to the institution’s mission.

🌍 Impact and Influence

Anil Kumar Gupta’s work extends beyond academia to influence national policy and governance in Nepal. His research and consultancy have played critical roles in assessing the country’s governance needs, supporting federal structures, and promoting gender-inclusive policies. His extensive experience and insights in public administration make him a key figure in Nepal’s policy landscape, where his contributions have informed significant reforms aimed at improving public service delivery and governance.

His professional contributions also include collaborative projects with international organizations, such as Harvard University, on evidence-based policy, and the Singapore Cooperation Enterprise, focused on public administration and governance. These experiences have broadened his perspectives, allowing him to bring innovative ideas to Nepal’s governance challenges.

🏅 Legacy and Future Contributions

Anil Kumar Gupta’s legacy is built upon his dedication to public service and governance improvement in Nepal. Through his research, training, and policy work, he has inspired a new generation of public administrators to prioritize inclusivity, transparency, and evidence-based policymaking. His current pursuit of a PhD signifies his commitment to continuous learning and development, positioning him to make even more profound contributions to Nepal’s development landscape.

Looking ahead, Anil aims to expand his research on political economy and governance, potentially exploring regional collaborations across South Asia to enhance administrative strategies. His goal is to foster an environment where governance practices are both progressive and culturally relevant, paving the way for a more equitable and inclusive Nepal.

🎓Publication 

Integrating Sustainable Development Goals in local plans: Unlocking practices and challenges of local governments in Nepal

  • Authors   : Gupta, A.K., Sigdel, T.S.
  • Journal    : Heliyon
  • Year         :2024

FROM TRADITIONAL TO INNOVATIVE PUBLIC SERVICE: A REVIEW OF PARADIGM SHIFTS

  • Authors   : Gupta, A.K., Lamsal, B.P.
  • Journal    : Public Administration Issues
  • Year         :2023

Service Users’ Confidence in Accessing Public Services in Nepal: What Makes Differences?

  • Authors   :Gupta, A.K., Bhurtel, A., Bhattarai, P.C.
  • Journal    :Journal of Policy Studies
  • Year         :2023

Bribing for Public Service: What Drives the Service Users?

  • Authors   : Bhattarai, P.C., Gupta, A.K.
  • Journal    : International Journal of Public Administration
  • Year         :2023

Civil servants’ integrity in public sector: the case of Nepal

  • Authors   : Khanal, R., Gupta, A.K., Bhattarai, P.C.
  • Journal    :Heliyon
  • Year         :2022

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Ronit Sverdlov|Pharmacology|Best Researcher Award

Prof Dr. Ronit Sverdlov at Maastricht University,Netherlands

PROFILE  

ORCID

Scopus

 

Early Academic Pursuits 🎓

Dr. Ronit Shiri-Sverdlov’s academic journey began with a Master’s degree in Biochemistry and Cellular Biology from Tel-Aviv University in Israel, where she graduated magna cum laude. This period was instrumental in shaping her deep interest in cellular and molecular mechanisms, a theme that would remain central to her later work. Building on her foundational knowledge, she pursued a Ph.D. in Molecular Genetics at Tel-Aviv University’s Sheba Medical Center, under the supervision of Prof. E. Friedman. Her doctoral research, focused on identifying germline mutations in the BRCA1 and BRCA2 genes among high-risk Jewish and Arab populations, underscored her commitment to precision genetics and earned her a magna cum laude distinction upon graduation in 2002.

Professional Endeavors 💼

Dr. Shiri-Sverdlov joined Maastricht University’s Department of Molecular Genetics in 2001 as a postdoctoral researcher, working with Prof. M.H. Hofker. Her early postdoctoral work provided the groundwork for her lifelong focus on metabolic health, hepatic inflammation, and cholesterol metabolism. In 2004, she transitioned into a faculty position, first as an Assistant Professor and later, an Associate Professor by 2012. In 2016, she was appointed a Full Professor of Hepatic Inflammation and Metabolic Health, reflecting her leadership and expertise in the field. Dr. Shiri-Sverdlov currently leads a vibrant research team within the Faculty of Health, Medicine, and Life Sciences at Maastricht University, where she oversees projects focusing on liver disease, metabolic health, and inflammation under the NUTRIM School of Nutrition and Translational Research in Metabolism.

Contributions and Research Focus 🔬

Dr. Shiri-Sverdlov’s research centers on understanding and combating liver-related diseases, particularly non-alcoholic steatohepatitis (NASH), through molecular insights into cholesterol trafficking and hepatic inflammation. Her investigations have brought critical attention to lysosomal dysfunction as a biomarker for early NASH detection. This research has garnered substantial support, including a €1 million TKI grant in 2017 and several large fellowships from the Dutch Digestive Foundation and NWO ZonMw. Her work emphasizes the role of cholesterol metabolism in Kupffer cells (liver macrophages) and its impact on inflammatory pathways—a field where her studies continue to yield promising therapeutic insights.

Accolades and Recognition 🏆

Over the years, Dr. Shiri-Sverdlov has earned numerous prestigious awards. Her early career was marked by the VENI, VIDI, and ASPASIA fellowships from NWO ZonMw, which collectively supported her pioneering work in cholesterol metabolism and liver inflammation. She received the Marie Sklodowska-Curie Seal of Excellence in 2018, reflecting her proposal’s high evaluation score. She was also awarded the Education Prize by Maastricht University in 2018 for her leadership in developing the Biomedical Sciences curriculum. Additionally, she has been nominated for multiple awards, reflecting her influence in both research and teaching.

Impact and Influence 🌐

Dr. Shiri-Sverdlov has made a significant impact in the field of hepatic health through her research and mentorship. Her work on hepatic lysosomal biomarkers has been pivotal in early disease detection for NASH, with implications for both clinical practice and drug development. As a member of key grant committees, including the Netherlands Organization for Scientific Research (NWO) and the Novo Nordisk Foundation, she actively shapes the research landscape. Her collaboration with researchers across Europe, including those at the University of Reading and Strasbourg University, has contributed to a robust network of shared knowledge and advances in metabolic health.

Legacy and Future Contributions 🌱

Looking to the future, Dr. Shiri-Sverdlov is committed to advancing the understanding of liver diseases through cutting-edge research. Her work not only contributes to therapeutic advancements in NASH and hepatic inflammation but also inspires the next generation of scientists. Through her teaching roles, she continues to influence and guide students in Biomedical Sciences and Nutrition, instilling in them a commitment to rigorous research. Her legacy is further enriched by her leadership in scientific societies, where she champions innovative approaches to metabolic and hepatic health research.

🎓Publication 

Plasma cathepsin D as an early indicator of alcohol-related liver disease

  • Authors   :Li, M., Houben, T., Bitorina, A.V., … Thiele, M., Shiri-Sverdlov, R.
    JHEP Reports,
  • Year         :2024

The Modulatory Effects of Fatty Acids on Cancer Progression

  • Authors   :Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., … Shiri-Sverdlov, R., Theys, J.
  • Journal    : Biomedicines
  • Year         :2023

All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma

  • Authors   :van Mourik, H., Li, M., Baumgartner, S., Theys, J., Shiri-Sverdlov, R.
  • Journal    :Biomedicines
  • Year         :2022

Fatty Acids as a Tool to Boost Cancer Immunotherapy Efficacy

  • Authors   : Westheim, A.J.F., Stoffels, L.M., Dubois, L.J., … Shiri-Sverdlov, R., Theys, J.
  • Journal    : Frontiers in Nutrition
  • Year         :2022

Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics

  • Authors   : Mokkala, K., Gustafsson, J., Vahlberg, T., … Plat, J., Laitinen, K.
  • Journal    :Nutrition, Metabolism and Cardiovascular Diseases
  • Year         :2022

Mr.Charles Opoku|Regulatory Affairs|Best Researcher Award

Published on by Top Pharmaceutical

Mr.Charles Opoku|Regulatory Affairs|Best Researcher Award

Mr.Charles Opoku at Fiaseman Senior High School,Ghana

PROFILE  

ORCID

 

Early Academic Pursuits 📚

Charles Boateng Opoku embarked on his academic journey with a strong foundation in social sciences, obtaining a Bachelor of Arts degree in Economics and Geography from the University of Cape Coast in 2009. His undergraduate project, titled “Effectiveness of Community Development Programmes in Improving the Livelihoods of Rural Dwellers,” underscored his early commitment to understanding and improving local communities’ well-being. His studies not only provided a solid understanding of economics and geography but also fostered his desire to make meaningful contributions to development and economic planning.

Following this, he further honed his expertise by completing an MSc in Development Planning and Management at the Kwame Nkrumah University of Science and Technology (KNUST) between 2014 and 2017. His research during this time focused on the vulnerabilities of farm households in Ghana, particularly those affected by socio-economic shocks, in the Tarkwa-Nsuaem Municipality. This research highlighted his dedication to examining the dynamics of development and resilience in rural contexts, laying the groundwork for his subsequent professional and research endeavors. Currently, Opoku is pursuing a PhD in Planning at KNUST, focusing his research on the determinants of informal land market outcomes, which has significant implications for spatial planning and policy in Ghana.

Professional Endeavors 👔

Charles Opoku’s professional career has been marked by a blend of teaching, research, and fieldwork. Since 2011, he has served as an Economics Tutor at Fiaseman Senior High School in Tarkwa, where he has educated and inspired young students in the Western Region of Ghana. His impact extends into higher education as an Adjunct Lecturer at the University of Cape Coast’s College of Distance Education since 2018. There, he teaches various subjects, including Microeconomics, the Economy of Ghana, and Entrepreneurship, helping students build foundational skills and knowledge for their careers.

Additionally, Opoku has contributed significantly to data collection and analysis in Ghana through his roles with the Ghana Statistical Service. In 2023, he acted as a Center Lead and Regional Trainer for the Integrated Business Establishment Survey. He also held key roles during the 2021 Population and Housing Census, serving as both a Municipal Field Supervisor and National Trainer, where he contributed to the accurate collection of demographic and economic data critical to national planning.

Contributions and Research Focus 🔬

Charles Opoku’s research and professional work have centered on a range of crucial topics, including land use planning, human settlement planning, and development economics. His PhD research on informal land markets in Ghana addresses important aspects of spatial planning, a field of study that is critical for sustainable urban development. Through his thesis, Opoku seeks to provide insights into the often-overlooked informal land market sector and the ways it impacts effective planning, governance, and policy implementation.

He has also conducted research on urban resilience and the vulnerabilities faced by farm households, contributing valuable knowledge to the field of development planning. In his publication “Vulnerability and Responses of Farm Households to Socioeconomic Shocks: Evidence from Tarkwa-Nsuaem Municipality of Ghana,” Opoku explored the resilience strategies of rural communities against economic disruptions. His work in the area of rural women’s economic empowerment in Ghana has been particularly influential, with his publication in the Journal of Agricultural Extension and Rural Development examining the impact of the Rural Enterprise Program (REP) on economic self-sufficiency and empowerment in rural areas.

Accolades and Recognition 🏅

Throughout his career, Opoku has earned recognition for his academic achievements and professional dedication. His membership in the Ghana Institute of Planning as a Graduate Trainee signifies his status as an emerging expert in the field. Additionally, he is an active member of Ghana’s Monitoring and Evaluation Forum and the Association of Certified Chartered Economists (ACCE), both of which highlight his commitment to continued professional growth and excellence.

Impact and Influence 🌍

Opoku’s work has had a lasting impact on the communities he serves, especially through his contributions to Ghana’s educational sector and his involvement in national surveys. By educating high school and university students, he helps shape the next generation of economists and planners, fostering a culture of analytical thinking and social responsibility. His role in data collection and research has directly contributed to national projects, including the 2021 Population and Housing Census, where his leadership as a trainer ensured the accuracy and reliability of critical demographic data. This data serves as the basis for policy decisions, resource allocation, and development planning in Ghana, underscoring Opoku’s significant role in shaping his country’s socio-economic landscape.

Legacy and Future Contributions 🌱

Charles Opoku’s legacy will likely be one of dedicated service to both academia and public policy. His ongoing research in informal land markets aims to inform policy and promote sustainable spatial planning practices, which will benefit urban and rural areas in Ghana. As he completes his PhD, he is well-positioned to become a thought leader in urban and regional planning, contributing to policies that prioritize equitable land use and sustainable development.

Looking to the future, Opoku envisions expanding his research to include broader aspects of urban resilience and green economy strategies. His goal is to support the development of Ghanaian communities that are not only resilient to economic shocks but also environmentally sustainable. As he continues his teaching, research, and contributions to data collection, his work will undoubtedly inspire future economists, planners, and policymakers in Ghana and beyond. Through his multifaceted career, Charles Boateng Opoku exemplifies the impact of thoughtful planning, dedicated teaching, and rigorous research in advancing both community resilience and national development.

 

🎓Publication 

Critical factors impacting psychosocial well-being of mining-induced displaced and resettled persons in Ghana

  • Authors   : Charles Boateng Opoku; Jonathan Kwofie; Millicent Awo Pomma Asirifi
  • Year         :2024

Economic empowerment of rural women: Assessing the effectiveness of the rural enterprise program (REP) in Ghana, West Africa

  • Authors   :Zahra Nekoukar , Shahram Ala, Siavash Moradi, Andrew Hill, Ali Reza Davoudi Badabi, Ahmad Alikhani, Shahriar Alian, Minoo Moghimi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
  • Journal    :Agricultural Extension and Rural Development
  • Year         :2022

Vulnerability and Responses of Farm Households to Socio-economic Shocks: Evidence from Tarkwa-Nsueam Municipality of Ghana

  • Authors   :Charles Boateng Opoku
  • Journal    : Innovative Research and Development
  • Year         :2020

 

Dr. Minoo Moghimi|Clinical Trials|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Minoo Moghimi|Clinical Trials|Best Researcher Award

Dr. Minoo Moghimi at Mazandaran University of Medical Sciences,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Minoo Moghimi embarked on her academic journey with a solid foundation in the National Organization for Development of Exceptional Talents, where she obtained her high school diploma in Yazd (2007-2011). This formative education laid the groundwork for her entrance into the field of pharmacy, where she pursued a PharmD at Yazd University of Medical Sciences from 2011 to 2018. Her early involvement with the faculty research committee highlighted her dedication to the field of pharmacotherapy, showcasing a keen interest in advancing pharmaceutical science right from the start.

Moghimi’s PharmD thesis focused on developing porous microencapsulated probiotics using a spray freeze drying technique. This innovative research emphasized the importance of drug formulation technology and aimed at enhancing probiotic viability. The success of this project led to a patent, marking a significant achievement in her early career and reflecting her capability to contribute meaningfully to pharmaceutical innovation.

Professional Endeavors 🏥

After completing her PharmD, Moghimi chose to channel her expertise into clinical applications by entering the Clinical Pharmacy Residency Program at Mazandaran University of Medical Sciences in 2018. This decision was driven by her passion for directly assessing drug effects in real-world patient scenarios. Throughout her residency, she demonstrated a profound dedication to clinical pharmacy, actively participating in research programs and engaging in numerous projects with a strong focus on clinical trials.

Her professional trajectory took a pivotal turn in 2020 during the COVID-19 pandemic when she contributed to the DISCOVER trial. This was a large-scale, randomized clinical trial involving over 1,000 patients, evaluating the efficacy of sofosbuvir and daclatasvir in treating hospitalized COVID-19 patients. The findings, published in the Journal of Antimicrobial Chemotherapy, were instrumental in understanding potential treatment options during the pandemic, reflecting her commitment to evidence-based clinical practice.

Moghimi’s professional expertise also extends beyond infectious diseases, as she has been involved in designing and implementing clinical trials in oncology, gynecology, and dentistry. Her diverse research portfolio underscores her adaptability and readiness to tackle multifaceted clinical challenges.

Contributions and Research Focus 📚

Minoo Moghimi’s primary research focus lies in managing chemotherapy-induced adverse effects, a critical area that significantly impacts cancer patient care. Her ongoing residency thesis, “Evaluation of the Efficacy and Safety of the Addition of Lacosamide to Duloxetine in the Treatment of Taxane-Induced Peripheral Neuropathy: A Randomized Double-Blind Placebo-Controlled Trial,” reflects this focus. Through this project, she aims to mitigate the debilitating side effects associated with chemotherapy, thus enhancing the quality of life for cancer patients.

In addition to her research in oncology, Moghimi has actively contributed to pharmacotherapy in critical care settings, clinical nutrition management, and drug-drug interaction management. Her ability to design comprehensive clinical trials is supported by her skills in clinical trial design, protocol development for critical medications, and medication reconciliation—skills that have proven vital in her multidisciplinary approach to patient care.

Moghimi’s contributions are not limited to clinical environments; she also engages in academic service. As a reviewer for respected journals like Pharmaceutical and Biomedical Research Journal (PBR) and Annals of Clinical and Medical Case Reports, she evaluates research, ensuring high standards in pharmacotherapy literature.

Accolades and Recognition 🏅

Throughout her academic and professional career, Minoo Moghimi has achieved several notable milestones. Her early achievement in patenting her thesis project during her PharmD studies reflects her commitment to innovation. During the COVID-19 pandemic, her role in the DISCOVER trial received significant recognition, as the study’s outcomes played a crucial role in informing clinical practices and treatment protocols for COVID-19 patients.

Impact and Influence 🌍

Minoo Moghimi’s research has had a tangible impact on the fields of clinical pharmacy and pharmacotherapy. Her work in chemotherapy-induced adverse effects, particularly taxane-induced peripheral neuropathy, aims to provide oncologists with better tools to manage the side effects of cancer treatments. By focusing on this critical aspect of cancer care, she is not only advancing research but also directly contributing to patient well-being, showcasing the transformative power of targeted pharmacotherapy.

Her involvement in critical care pharmacotherapy, nutrition management, and drug-drug interaction management demonstrates a holistic approach to patient care, where she considers various factors influencing therapeutic outcomes. This multidisciplinary expertise positions her as a key contributor to advancing patient-centered care in clinical settings.

Legacy and Future Contributions 🌟

Looking ahead, Minoo Moghimi aims to continue her work at the intersection of research and clinical practice. Her focus on chemotherapy-induced adverse effects, critical care, and nutrition management indicates a commitment to advancing patient care through evidence-based research. As a Board Certified Pharmacotherapy Specialist, her goal is to bridge the gap between research and clinical applications, ensuring that pharmacotherapy evolves in response to patient needs.

In the future, Moghimi plans to expand her research into novel drug therapies, aiming to develop innovative interventions for managing complex clinical conditions. Her dedication to the peer-review process reflects her intention to contribute to the scientific community by ensuring the dissemination of accurate and impactful research findings.

Skills and Technological Expertise 💻

Minoo Moghimi possesses a diverse skill set encompassing clinical trial design, research management, and critical care pharmacotherapy. Her expertise extends to protocol development for high-risk drugs, clinical nutrition, and drug-drug interaction management. In terms of technical skills, she is proficient with software like GraphPad Prism, Endnote, and MS Office—tools that are essential for managing data, conducting statistical analysis, and organizing research findings.

Research Interests and Aspirations 🔬

Her primary research interests revolve around chemotherapy-induced adverse effects, a field that holds immense potential for improving cancer care outcomes. Moghimi is also dedicated to critical care pharmacotherapy and nutrition management, fields where she hopes to make significant contributions in the future. Her aspiration is to develop strategies and guidelines that healthcare professionals can utilize to optimize treatment outcomes in complex clinical scenarios.

Conclusion 🎯

Minoo Moghimi’s journey from a dedicated pharmacy student to a Board Certified Pharmacotherapy Specialist is marked by a strong academic foundation, substantial research contributions, and a commitment to improving patient care. Her work has already left an indelible mark on the clinical pharmacy landscape, and her ongoing projects promise to further enhance therapeutic approaches in critical care and oncology. Moghimi’s career is a testament to the profound impact that dedicated research, clinical expertise, and a patient-centered approach can have in advancing healthcare.

🎓Publication 

A Narrative Review on Adverse Effects of Dasatinib With a Focus on Pharmacotherapy of Dasatinib-Induced Pulmonary Toxicities

  • Authors   :Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
  • Journal    :Blood Research
  • Year         :2021

Evaluation of the Effect of Sofosbuvir and Daclatasvir in Hospitalised COVID-19 Patients: A Randomized Double-Blind Clinical Trial (DISCOVER)

  • Authors   : Sara Mobarak, Mehdi Salasi, Ahmad Hormati, Javad Khodadadi, Masood Ziaee, Farshid Abedi, Azadeh Ebrahimzadeh, Zohreh Azarkar, Fariborz Mansour-Ghanaei, Farahnaz Joukar, Sara Yeganeh, Tofigh Yaghubi Kalurazi, Mohammadreza Naghipour, Zeinab Mehrabi, Amir Reza Bahadori, Shoeleh Yaghoubi, Rohollah Moslemi, Hamideh Abbaspour Kasgari, Hafez Fakheri, Minoo Moghimi, Amir Mohammad Shabani, Zahra Nekoukar, Farhang Babamahmoodi, 
  • Year         :2025

Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with moderate COVID-19, A

  • Authors   :Zahra Nekoukar , Shahram Ala, Siavash Moradi, Andrew Hill, Ali Reza Davoudi Badabi, Ahmad Alikhani, Shahriar Alian, Minoo Moghimi, Amir Mohammad Shabani, Hamideh Abbaspour Kasgari
  • Journal    :Iranian Journal of Pharmaceutical Research
  • Year         :2021

Suicide attempt using zinc phosphide rodenticide: A case report and literature review

  • Authors   :Zahra Nekoukar, Minoo Moghimi, Kimia Rasouli, Aref Hoseini, Zakaria Zakariaei, Rabeeh Tabaripour, Mahdi Fakhar, Elham Sadat Banimostafavi 
  • Journal    : Clinical case reports
  • Year         :2021

Prevalence of Thromboembolic Events, Including Venous Thromboembolism and Arterial Thrombosis, in Patients with COVID-19: A Systematic Review with Meta-Analysis

  • Authors   :Babak Bagheri, Abbas Alipour, Mojtaba Yousefi, Rozita Jalalian, Minoo Moghimi, Mahsa Mohammadi, Negar Hassanpour, Mohammadreza Iranian
  • Journal    :Tehran University of Medical Sciences
  • Year         :2023

Mr.Chunyuan Ping|Biopharmaceutics|Best Researcher Award

Published on by Top Pharmaceutical

Mr.ChunyuanPing|Biopharmaceutics|Best Researcher Award

Mr.Chunyuan Ping at Sichuan Toruism University,China

PROFILE  

 

Scopus

Early Academic Pursuits 📚

Chunyuan Ping’s academic journey began with a deep interest in the science of food processing and safety. After completing both Bachelor’s and Master’s degrees at the Henan Institute of Science and Technology, Ping honed a unique skill set in Agricultural Products Processing and Safety. This educational background offered a foundation in food science, which Chunyuan fortified with hands-on experience in food chemistry, sensory evaluation, and chemometrics. Through rigorous study and research, Ping developed expertise in critical methodologies like the Mantel test, statistical software such as Origin, SIMCA, and Design-Expert, and analysis tools including IBM SPSS, TBtools, and EndNote.

Professional Endeavors and Contributions 🔍🍲

Since 2022, Ping has been actively engaged in advanced research focusing on agricultural product processing, with a particular focus on volatile organic compounds (VOCs) and flavor chemistry. With a skillset in chemometric techniques, Ping has led several studies analyzing food products using High Sensitivity Gas Chromatography-Ion Mobility Spectrometry (HS-GC-IMS). In 2024, Ping published work in Food Chemistry: X, where the characteristic flavor quality of ceramic-pot sealed meat was evaluated post-reheating. This study utilized bionic sensory techniques combined with chemometrics to reveal the dynamic sensory attributes and chemical properties of this traditional culinary method, making substantial contributions to the field.

Ping’s expertise extends into multivariate statistics and sensory analysis, evidenced by research on Linjiangsi Broad Bean paste, where the effect of ripening time and fermentation environment on flavor profiles was examined. This project brought valuable insights into the traditional bean paste’s sensory characteristics and chemical profile. Another significant contribution was Ping’s study on high-temperature sterilization and pasteurization’s impact on volatile compounds in tomato stewed beef brisket, published in International Journal of Gastronomy and Food Science, advancing the understanding of processing techniques on flavor retention and modification.

Research Focus and Expertise 🎨🔬

Ping’s research interests lie in the interaction and degradation of volatile organic compounds within processed foods, specifically focusing on flavor profile preservation and enhancement. This focus has driven Chunyuan to conduct innovative studies on various traditional and modern processing techniques, using state-of-the-art tools like gas chromatography and multivariate analysis. Ping is particularly interested in how different sterilization methods, both thermal and nonthermal, influence flavor retention in complex dishes like lamp soup, with a master’s thesis dedicated to this topic.

Ping’s expertise in statistical and visual data representation has also significantly contributed to the ability to quickly produce high-quality figures and tables that support scientific claims and enhance research readability. This skill has proven instrumental in rapidly publishing in open-access (OA) journals, where effective data visualization is critical to reaching a broader scientific audience.

Accolades and Recognition 🌟🏅

Though still early in Ping’s career, the researcher’s work has already earned notable accolades in the field. Publications in high-impact journals, such as Food Chemistry: X and International Journal of Gastronomy and Food Science, showcase Ping’s scientific contributions and recognition among the academic community. These publications highlight Ping’s capability to independently conduct rigorous research and contribute significantly to food science literature. Additionally, the collaborative works listed, where Ping is often a co-author or a principal investigator, underscore Ping’s skill in teamwork and scientific communication, further establishing Ping’s reputation in agricultural and food chemistry research.

Impact and Influence 🌐📊

Ping’s research in food processing and safety has both immediate and far-reaching implications. By focusing on the preservation of flavor in prepared foods, Ping’s studies offer practical applications in the food industry, where maintaining flavor quality is paramount. The analyses conducted by Ping help streamline food processing techniques, making it possible to retain natural flavors without sacrificing food safety. These advancements contribute to the field by offering more sustainable and efficient methods, which benefit both industry professionals and consumers. Furthermore, the studies provide a reference point for future food safety research, potentially influencing policy in food processing standards.

Legacy and Future Contributions 🚀📈

Chunyuan Ping’s journey in the field of food science and safety is only beginning. Driven by a passion for exploring the complex interactions of VOCs and a keen interest in advancing food chemistry, Ping aspires to pursue a Ph.D. to gain more specialized knowledge and refine research methodologies. With a clear direction and an established foundation, Ping’s future work aims to provide actionable insights into the degradation and preservation of volatile compounds in processed foods. By continuing to publish and contribute to scientific literature, Ping is poised to become an influential figure in food science, especially in the field of flavor chemistry.

Through this ongoing research, Ping hopes to make lasting contributions that will not only advance scientific knowledge but also create a legacy of innovation within food chemistry and agricultural product processing. By enhancing methods of flavor preservation and quality control, Ping’s work could impact industry standards and contribute to healthier, better-tasting food products worldwide.

🎓Publication 

Evaluating the influence of high-temperature sterilization and pasteurization on volatile organic compounds in tomato stewed beef brisket: An analysis using gas chromatography-ion mobility spectrometry and multivariate statistical visualization

  • Authors   :Bi, J., Ping, C., Chen, Z., … Zhang, Y., He, H.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2024

Comparative study of volatile flavor compounds in green onion (Allium fistulosum L.) processed with different cooking methods

  • Authors   : Bi, J., Li, B., Chen, Z., … Zhang, Y., Zhang, L.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2024

Mining of kokumi peptides in chicken broth with peptidomics

  • Authors   :Li, Y., Bi, J., Lin, Z., … Ping, C., Chen, Z.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2023

Analysis of the effect of steaming times on lipid composition of pork belly based on lipidomics technology

  • Authors   :Bi, J., Li, Y., Yang, Z., … Ping, C., Chen, Z.
  • Journal    :Journal of Food Composition and Analysis
  • Year         :2023

Effects of different cooking methods on volatile flavor compounds in garlic

  • Authors   :Bi, J., Yang, Z., Li, Y., … Chen, Z., Li, C.
  • Journal    :International Journal of Gastronomy and Food Science
  • Year         :2023

Dr. John Thometz|Pharmaceutical Analysis|Excellence in Reach Award

Published on by Top Pharmaceutical

Dr.JohnThometz|Pharmaceutical Analysis|Excellence in Reach Award

Dr. John Thometz at Medical College of WI,United States

PROFILE  

 

Scopus

🏫 Early Academic Pursuits

Dr. John G. Thometz embarked on his academic journey in medical sciences with a strong foundation at Northwestern University, where he earned a Bachelor of Science in Medicine (B.S.M.) in 1973. His commitment to global understanding in medicine took him to Loyola University in Rome, Italy, where he furthered his education in 1974. Dr. Thometz then completed his medical degree (M.D.) at Northwestern Medical School in 1978, after which he was awarded a surgical scholarship at Addenbrooke’s Hospital in Cambridge, England. These experiences laid the groundwork for his illustrious career in orthopedic surgery, with a specialization in pediatric orthopedics.

🩺 Professional Endeavors

Dr. Thometz’s professional career began with intensive training, including a general surgery internship at Loyola University in Chicago, followed by a residency in orthopedic surgery at Northwestern University. His desire to make an impact in pediatric orthopedics led him to Harvard University’s Children’s Hospital, where he completed a fellowship in 1985. Soon after, he joined the Medical College of Wisconsin, where he served as Assistant Professor in the Department of Orthopaedic Surgery. Over the years, his dedication and expertise were recognized with progressive appointments, eventually reaching the rank of Professor in 2000. Dr. Thometz has also held a long-standing role as Adjunct Professor at Marquette University’s Orthopaedic and Rehabilitation Engineering Center (OREC), bridging academic and clinical disciplines.

🔬 Contributions and Research Focus

Dr. Thometz’s research has significantly advanced pediatric orthopedics, with a focus on developing innovative treatments and technologies for children with musculoskeletal disorders. His research spans early-onset scoliosis, cerebral palsy, and spinal deformities. His projects include contributions to critical studies on casting versus bracing in scoliosis treatment, funded by the Orthopaedic Research and Education Foundation (OREF), and a novel study on dynamic pedorthosis for clubfoot correction. In collaboration with the U.S. Department of Health and Human Services and the National Institute on Disability and Rehabilitation Research (NIDILRR), Dr. Thometz has led initiatives to train physicians and engineers in advanced pediatric rehabilitation.

🏅 Accolades and Recognition

Dr. Thometz’s dedication to orthopedic surgery has been widely recognized through numerous accolades, highlighting his commitment to excellence in both teaching and clinical practice. He was named Teacher of the Year twice by the Medical College of Wisconsin’s Department of Orthopaedic Surgery (1988, 2000) and awarded the prestigious Louis A. Goldstein Award for Best Clinical Poster Presentation at the 2010 Scoliosis Research Society Annual Meeting. His expertise has also earned him a consistent place on the Best Doctors in America list, as well as recognition by MKE Lifestyle Magazine for multiple years, underscoring his impact in Milwaukee and beyond.

🌍 Impact and Influence

Beyond his immediate clinical and teaching roles, Dr. Thometz has made substantial contributions to the orthopedic community nationally and internationally. He is an active member and fellow of esteemed organizations, including the American Academy of Orthopaedic Surgeons, the Pediatric Orthopaedic Society of North America, and the Scoliosis Research Society. His work in these societies has focused on advancing pediatric orthopedics and influencing guidelines on nonoperative management strategies, particularly in scoliosis care.

🏛️ Legacy and Future Contributions

As a pioneer in pediatric orthopedic surgery, Dr. Thometz has contributed to foundational research and mentorship that continue to shape the field. His leadership as Medical Director of Pediatric Orthopedic Surgery at the Children’s Hospital of Wisconsin spanned three decades, culminating in his role as Emeritus Medical Director for the Spina Bifida program. Dr. Thometz’s work on advanced rehabilitation technologies and orthopedic interventions continues through his position as Co-Program Director of the Advanced Rehabilitation Research Training (ARRT) in Pediatric Mobility. His legacy is further carried on by his students and residents, many of whom have become leaders in orthopedics. Dr. Thometz’s future contributions are poised to focus on guiding new research, particularly in enhancing pediatric mobility and rehabilitation, with a continued commitment to improving the quality of life for children globally.

🎓Publication 

Analysis of adolescent idiopathic scoliosis population for Surgical Site Infection Risk Factors

  • Authors   :Fletcher, J., Liu, X.-C., Thometz, J.G.
  • Journal    :Journal of Orthopaedics
  • Year         :2025

Correlation of transverse rotation of the spine using surface topography and 3D reconstructive radiography in children with idiopathic scoliosis

  • Authors   : Patel, M., Liu, X.-C., Tassone, C., … Yang, K., Thometz, J.
  • Journal    :Spine Deformity
  • Year         :2024

3D Back Contour Metrics in Predicting Idiopathic Scoliosis Progression: Retrospective Cohort Analysis, Case Series Report and Proof of Concept

  • Authors   : Patel, M., Liu, X.-C., Yang, K., … Escott, B., Thometz, J.
  • Journal    :Children,
  • Year         :2024

Prophylactic Spinal Cord Untethering in Children with Spinal Dysraphism Undergoing Thoracolumbar Fusion for Scoliosis

  • Authors   :Bureau, B.L., Sherburne, E., Thometz, J.G., Foy, A.B.
  • Journal    :World Neurosurgery
  • Year         :2023

Preoperative left shoulder elevation > 1 cm is predictive of severe postoperative shoulder imbalance in early onset idiopathic scoliosis patients treated with growth-friendly instrumentation

  • Authors   :Li, Y., Yang, D., Bergman, R., … Yazici, M., Zhang, T.J.
  • Journal    :Spine Deformity
  • Year         :2023

Dr. Annie Zhang|Immunotherapy|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Annie Zhang|Immunotherapy|Best Researcher Award

Dr. Annie Zhang at Cambridge,United States

PROFILE  

 

Scopus

Dr. Annie Zhang embarked on her academic journey with a strong foundation in medicine and public health, earning an MD and an MPH. Her dual degrees equipped her with a nuanced understanding of clinical medicine and the critical public health frameworks essential for managing and preventing diseases at both population and individual levels. Driven by a commitment to advancing therapeutic options and improving patient outcomes, she honed her knowledge in both biostatistics and epidemiology. These skills have been foundational throughout her career, particularly in her roles focused on evidence generation and clinical research.

🌟 Professional Endeavors

Throughout her distinguished career, Dr. Zhang has held senior roles at prominent pharmaceutical companies, demonstrating her expertise in medical affairs, clinical research, and strategic evidence generation.

  1. Sanofi, Cambridge, MA
    As the Global Senior Medical Director in Immunology & Dermatology since 2018, Dr. Zhang has led impactful initiatives in Medical Evidence Generation within Global Medical Affairs. Her key achievements include winning Sanofi’s “Best of Best” award in 2023 and receiving a 1st Place Poster award at the American Academy of Dermatology (AAD) conference in 2024 for her work’s scientific importance. Her leadership has propelled Sanofi’s immunology initiatives, particularly through studies such as PEDISTAD and INFANTSTAD, which focus on disease modification and prevention of the atopic march.
  2. Apellis, Waltham, MA
    In her tenure as Medical Director at Apellis from January 2017 to December 2017, Dr. Zhang was responsible for strategic planning and clinical development in hematology, overseeing Phase II and III studies in conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and autoimmune hemolytic anemia (AIHA). Her role included extensive interaction with thought leaders and the clinical team to design and optimize trial strategies.
  3. Biogen, Cambridge, MA
    From 2009 to 2016, Dr. Zhang held several pivotal roles at Biogen, advancing from Medical Director in Global Medical Affairs to leading biostatistical teams for key drug programs like Tecfidera. She worked on Tysabri’s lifecycle management, supporting clinical trial design, data generation, and publication strategies, especially in multiple sclerosis (MS). Her expertise in biostatistics and clinical research design strengthened Biogen’s data-driven approaches, particularly in Phase III and IV clinical trials.
  4. PAREXEL International, Lowell, MA
    Dr. Zhang worked as a Senior Biostatistician at PAREXEL from 2007 to 2009, leading biostatistical tasks across diverse therapeutic areas, including oncology, CNS disorders, and cardiovascular disease. Her meticulous approach ensured the quality and accuracy of statistical reports for clinical trials, contributing to numerous successful projects within the biostatistics team.
  5. New England Research Institutes, Watertown, MA
    Early in her career, Dr. Zhang served as an Associate Research Scientist at NERI from 2000 to 2007, where she conducted critical statistical analyses for clinical research, laying the groundwork for her later expertise in biostatistics and clinical study design.

💡 Contributions and Research Focus

Dr. Zhang’s research has centered around dermatology, immunology, and hematology. At Sanofi, her work in immunology has led to groundbreaking insights on skin barrier integrity and neuroimmune function, providing essential evidence for the prevention of atopic march. She has also driven significant advancements in real-world evidence generation, particularly in cross-functional collaboration with global market access and regulatory teams, demonstrating her strategic alignment with organizational goals and patient needs.

🏆 Accolades and Recognition

Dr. Zhang’s achievements have earned her numerous accolades, including the prestigious “Best of Best” award at Sanofi in 2023. In addition, she received 1st Place at the AAD 2024 Poster Award for her study on skin barrier health. Her work has also made her one of the most-read and cited authors in Allergy and Pediatric Dermatology in 2024, underscoring her impact and visibility in her field.

🌐 Impact and Influence

Through her extensive collaborations, Dr. Zhang has influenced clinical practices and regulatory frameworks worldwide. Her involvement in key study proposals and evidence generation initiatives has significantly impacted the medical community’s understanding of dermatological conditions. Her efforts in strategic planning, data generation, and cross-functional teamwork have positioned her as an influential figure in dermatology and immunology, particularly in advancing therapies that meet rigorous safety and efficacy standards.

🌱 Legacy and Future Contributions

Dr. Zhang’s legacy lies in her innovative approach to medical evidence generation and her unwavering commitment to patient-centered research. Her leadership in studies such as PEDISTAD and INFANTSTAD has set new standards for clinical research in dermatology and immunology. As she continues her work at Sanofi, Dr. Zhang’s contributions promise to expand the understanding and treatment of complex immunological conditions, impacting healthcare practices on a global scale.

Through her career, Dr. Zhang has exemplified excellence, dedication, and a strategic vision, ensuring her place as a respected leader in the pharmaceutical and clinical research sectors. Her ongoing work will undoubtedly continue to shape medical innovations and patient care improvements, leaving a lasting legacy in the fields of immunology and dermatology.

🎓Publication 

Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM

  • Authors   :Fox, R.J., Gold, R., Phillips, J.T., … Zhang, A., Marantz, J.L.
  • Journal    :Neurology and Therapy
  • Year         :2017

Number Needed to Treat in Multiple Sclerosis Clinical Trials

  • Authors   : Okwuokenye, M., Zhang, A., Pace, A., Peace, K.E.
  • Journal    :Neurology and Therapy
  • Year         :2017

Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis

  • Authors   : Fox, R.J., Chan, A., Zhang, A., … Edwards, M.R., Marantz, J.L
  • Journal    :Current Medical Research and Opinion
  • Year         :2017

Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies

  • Authors   :Gold, R., Giovannoni, G., Phillips, J.T., … Zhang, A., Marantz, J.L.
  • Journal    :Neurology and Therapy
  • Year         :2016

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS

  • Authors   :Spelman, T., Kalincik, T., Jokubaitis, V., … Trojano, M., Butzkueven, H.
  • Journal    :Neurology: Clinical Practice
  • Year         :2016

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor at Department of General and Transplantation Surgery, Medical University of Warsaw,Poland

PROFILE  

 

Scopus

Early Academic Pursuits 🎓

Professor Piotr Fiedor, MD, PhD, embarked on his medical journey with a strong focus on surgery and transplantation. His academic pursuits began at Warsaw Medical University, where he completed his initial medical training. Earning both his MD and PhD, Fiedor developed a passion for complex medical fields such as transplantation immunology and biotechnology. During his early career, he broadened his expertise with international fellowships, notably at Columbia University in the United States, between 1993 and 1996, where he deepened his knowledge in transplantation immunology and immunomodulation. This fellowship solidified his expertise and set the stage for his contributions to both academia and the field of transplantation surgery.

Professional Endeavors 🔬

Professor Fiedor’s professional career has been a blend of clinical practice, research, and leadership roles. Since 1995, he has served in the Department of General and Transplantation Surgery at Warsaw Medical University. His responsibilities in this department include managing clinical procedures, conducting high-level research, and overseeing scientific programs. In addition to his academic role, Fiedor held the prestigious position of Chief Executive Officer at the National Medicine Institute in Warsaw from 2015 to 2017. During this period, he was responsible for overseeing the evaluation of medicinal products, ensuring high-quality standards, and coordinating with the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Fiedor’s influence extends to regulatory affairs, particularly as the Polish Member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) from 2010 to 2017. His contributions in the CHMP involved acting as Rapporteur or Co-Rapporteur for more than 120 innovative medicinal products, ensuring their safe and effective use across Europe. His regulatory expertise continues, as he now serves as an Expert for the CHMP Scientific Advice Group.

Contributions and Research Focus 🧬

Professor Fiedor’s research has had a profound impact on the fields of transplant surgery, oncology, and immunology. His scientific work has addressed critical challenges in organ transplantation, including the immunological complications of transplants and strategies for improving graft survival. His work on the hemodynamic changes in organ donors before harvesting has been particularly influential, contributing to improved transplantation outcomes.

International collaborations have been a cornerstone of his research. He has worked with institutions like L’Aquila University in Italy, Columbia University and Ohio State University in the United States, and the Hebrew University of Jerusalem in Israel. His participation in 15 national scientific projects supported by Poland’s National Scientific Committee and two research grants from the National Institutes of Health (NIH) in the USA highlight his commitment to advancing medical science on a global scale.

Accolades and Recognition 🏅

Throughout his career, Professor Fiedor has received numerous awards recognizing his contributions to medical science, education, and public health. Some of his most notable honors include:

  • The Gold Cross of Merit awarded by the President of Poland in 2011 for his exceptional service to medicine.
  • The National Education Committee Medal in 2009 for his contributions to the advancement of medical education.
  • Multiple scientific awards from Warsaw Medical University, including team and individual awards for groundbreaking research on organ transplantation and immunology.
  • A notable achievement is his 2012 First-Degree Team Teaching Award from the Rector of Warsaw Medical University for co-authoring a textbook on disaster medicine.

These awards underline his influence on both medical practice and education.

Impact and Influence 🌍

Professor Fiedor’s impact extends beyond his clinical and research achievements. As a member of international organizations like the International Transplantation Society and the American Society of Transplant Surgeons (ASTS), he has helped shape the global discourse on transplant surgery and immunology. His work has led to significant advances in transplantation procedures, particularly concerning immunosuppressive therapies that reduce the risk of organ rejection.

In addition to his clinical and research accomplishments, Fiedor has played a vital role in shaping regulatory policies for medicinal products in Poland and Europe. His expertise in clinical trials, particularly through his work at the National Medicines Institute and his leadership in Good Clinical Practice (GCP) inspections, has influenced the standards of medical product approvals across Europe.

Legacy and Future Contributions 🌟

Professor Fiedor’s legacy lies in his multifaceted contributions to medicine. He has influenced generations of surgeons and medical professionals through his teaching roles at Warsaw Medical University. His over 210 scientific papers and 19 book chapters serve as valuable resources for both current and future medical researchers. His dedication to personalized medicine and biotechnology continues through his involvement in organizations such as the International Consortium for Personalized Medicine (IC PerMed), where he plays a role in advancing tailored healthcare solutions.

Looking forward, Fiedor’s ongoing work with European Joint Programs for Rare Diseases and the National Center for Research and Development’s Alpha Bridge Project ensures that he will continue to contribute to innovative research in the field of rare diseases and healthy society initiatives.

Conclusion 🔖

Professor Piotr Fiedor’s career stands as a testament to his dedication to the fields of surgery, immunology, and transplantation. With a rich history of academic achievements, clinical leadership, and regulatory expertise, his contributions have reshaped modern medicine, particularly in the realms of organ transplantation and medicinal product evaluation. His legacy continues to inspire both his peers and the next generation of medical professionals.

🎓Publication 

One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing

  • Authors   : Gościniak, A., Stasiłowicz-Krzemień, A., Michniak-Kohn, B., Fiedor, P., Cielecka-Piontek, J.
  • Journal    :Molecules
  • Year         :2024

Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers

  • Authors   : Bartoszewicz, M., Prokop, P., Kosieradzki, M., Fiedor, P.
  • Journal    :Transplantation Proceedings
  • Year         :2024

Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency—A One-Center Experience

  • Authors   : Prokop, P., Bartoszewicz, M., Gardyszewska, A., Kosieradzki, M., Fiedor, P.
  • Journal    :ransplantation Proceedings
  • Year         :2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial

  • Authors   :Rejdak, K., Fiedor, P., Bonek, R., … Kaczor, M., Grieb, P.
  • Journal    :European Journal of Neurology
  • Year         :2024

POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020–2021)

  • Authors   :Suwalska, A., Tobiasz, J., Prazuch, W., … Cieszanowski, A., Polanska, J.
  • Year         :2023

Prof. Satyanarayana Gedu|Pharmaceutical Chemistry|Best Researcher Award

Published on by Top Pharmaceutical

Prof.SatyanarayanaGedu|Pharmaceutical Chemistry|Best Researcher Award

Prof. Satyanarayana Gedu at Indian Institute of Technology Hyderabad,India

PROFILE  

orcid

Scopus

Dr. G. Satyanarayana’s academic journey began with a stellar performance during his undergraduate studies at Andhra University. From 1994 to 1996, he pursued a Bachelor of Science degree in Mathematics, Physics, and Chemistry (M.P.C), where he showcased exceptional talent, securing an impressive 87% and achieving first rank in his class. His academic excellence was acknowledged with a gold medal, symbolizing his hard work and dedication. His early focus on chemistry laid the foundation for a lifelong commitment to research in organic chemistry.

Following his undergraduate success, Dr. Satyanarayana pursued a Master of Science in Organic Chemistry from Andhra University from 1996 to 2001. He earned a first-class distinction with 70.5% marks, further solidifying his interest in organic chemistry. His strong foundation in organic chemistry and research potential set him on the path toward further academic achievements, ultimately leading him to a Ph.D. at the prestigious Indian Institute of Science (IISc) Bangalore.

Doctoral Research and Advanced Studies 🧑‍🔬

Dr. Satyanarayana embarked on his Ph.D. journey in 2001 under the guidance of Professor A. Srikrishna at the Indian Institute of Science. His research focused on organic synthesis, specifically the “Synthesis of (+)-Allopupukeanones, (–)-Valeriananoids and (±)-Herbertanes,” demonstrating his advanced understanding of complex organic compounds. By 2005, he successfully completed his doctoral work, earning recognition for his innovative approach and significant contributions to the field of organic synthesis.

Professional Endeavors and Global Exposure 🌍

Following his Ph.D., Dr. Satyanarayana’s academic career took him on an international trajectory. His postdoctoral research was shaped by prestigious fellowships and positions in renowned institutions. From December 2005 to November 2006, he worked as a Research Associate at the Department of Organic Chemistry, IISc Bangalore, before being awarded the Alexander von Humboldt (AvH) Postdoctoral Fellowship in 2006. This prestigious fellowship took him to the University of Tübingen, Germany, where he conducted advanced research in organic chemistry from February 2007 to June 2008.

Building on his international research experience, Dr. Satyanarayana then joined the University of Heidelberg in Germany as a Postdoctoral Research Fellow from October 2008 to September 2009. His time in Germany helped him gain valuable insights into cutting-edge organic chemistry research, broadening his expertise in synthesis and molecular structures.

Contributions and Research Focus 🔬

Dr. Satyanarayana’s primary research focus lies in the domain of organic synthesis, with a particular emphasis on the total synthesis of natural products. His work has contributed to advancements in synthetic methodologies, specifically in the creation of complex organic molecules. His research on the synthesis of Allopupukeanones, Valeriananoids, and Herbertanes, along with other compounds, showcases his expertise in designing novel synthetic routes, which have potential applications in pharmaceuticals and material science.

Throughout his career, Dr. Satyanarayana has published extensively in leading chemistry journals, contributing to the global body of knowledge in organic chemistry. His research not only highlights his dedication to expanding scientific understanding but also demonstrates the real-world implications of his work in industries such as drug discovery and development.

Accolades and Recognition 🏆

Dr. Satyanarayana’s exceptional contributions to academia and research have been widely recognized. Early in his career, he received a Junior Research Fellowship (JRF) from the Council for Scientific and Industrial Research (CSIR) in 2002, placing him among the top 20% of students in the nation. He also qualified for the Graduate Aptitude Test in Engineering (GATE) in 2001, securing an outstanding 98.47 percentile and earning an All India 28th rank.

His Ph.D. work at IISc earned him the coveted Gold Medal and Merit Certificate for Best Thesis in 2006, awarded by the Department of Organic Chemistry, IISc. This recognition was a testament to his innovative and impactful research contributions. Furthermore, he received the prestigious Alexander von Humboldt (AvH) Fellowship in 2006, which opened the door to further global research opportunities in Germany.

Over the years, Dr. Satyanarayana has been awarded multiple accolades for his excellence in teaching and research. In 2016 and 2020, he received the Best Teacher Award at IIT Hyderabad, highlighting his significant impact on students and the academic community. His outstanding achievements also earned him the Thieme Chemistry Journal Award in 2016, recognizing his contributions to the global chemistry community.

Impact and Influence on Academia and Research 📚

Dr. Satyanarayana’s influence extends beyond his research contributions. As a faculty member at the Indian Institute of Technology (IIT) Hyderabad, he has played a pivotal role in mentoring and shaping the next generation of chemists. His passion for teaching, coupled with his extensive research background, has made him a respected figure in the academic community. His commitment to guiding students in their academic and research pursuits has left a lasting impact on many budding chemists.

In addition to teaching, Dr. Satyanarayana’s research continues to inspire further investigations into organic synthesis and molecular chemistry. His innovative approaches and synthesis strategies serve as a reference point for researchers working on complex molecular synthesis worldwide.

Legacy and Future Contributions 🌱

Dr. Satyanarayana’s legacy is defined by his remarkable academic achievements, pioneering research, and unwavering dedication to education. His contributions to organic chemistry, particularly in the field of total synthesis, have paved the way for new discoveries in pharmaceuticals and material science. As he continues to mentor students and contribute to cutting-edge research at IIT Hyderabad, his work will undoubtedly inspire future chemists to push the boundaries of scientific exploration.

Looking ahead, Dr. Satyanarayana is poised to further enhance his impact on both the academic and research fields. With a strong foundation of accomplishments and recognition from global institutions, his future contributions will likely continue to shape the direction of organic chemistry research, making a lasting difference in science and society.

🎓Publication 

Electrochemical selenofunctionalization of unactivated alkenes: access to β-hydroxy-selenide

  • Authors   :Anil Balajirao Dapkekar; Gedu Satyanarayana
  • Journal    :Organic & Biomolecular Chemistry
  • Year         :2024

Electrochemical stereoselective borylation of Morita–Baylis–Hillman adducts to functionalized allylic boronates

  • Authors   :Jagadeesh Reddy Thondur; Duddu S. Sharada; Gedu Satyanarayana
  • Journal    :Chemical Communications
  • Year         :2024

Electrochemically driven regioselective construction of 4-sulfenyl-isochromenones from o-alkynylbenzoates and diaryl disulfides

  • Authors   : Anil Balajirao Dapkekar; Gedu Satyanarayana
  • Journal    :Organic & Biomolecular Chemistry
  • Year         :2024

Palladium catalyzed remote-meta-C–H functionalization of aniline scaffolds

  • Authors   : Dasari Srinivas; Gedu Satyanarayana
  • Journal    :Organic Chemistry Frontiers
  • Year         :2024

An acid-mediated synthesis of substituted naphthalenes from ortho-alkynyl tertiary benzylic alcohols

  • Authors   :Puja Singh; Sreenivasulu Chinnabattigalla; Komal Goel; Ravi Kishore Dakoju; Satyanarayana Gedu
  • Journal    :Tetrahedron
  • Year         :2024